Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 25, 2001BMJOpen Access

Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trialCommentary: cost and resistance remain issues

View Full Paper
Ask AI
Bookmark
Share

Authors

SSShyam SundarGAGaurav AgrawalMMM K Makharia

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sundar et al. (2001) studied this question.

synapsesocial.com/papers/6a99d0f92a60c81fa4abff64https://doi.org/10.1136/bmj.323.7310.419
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India Commentary: Some good news for treatment of visceral leishmaniasis in Bihar1998 · 170 citations
  2. 2Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: a multicenter study.2002 · 101 citations
  3. 3Treatment of visceral leishmaniasis (kala-azar): A decade of progress and future approaches2000 · 115 citations
  4. 4Miltefosine — The Long-Awaited Therapy for Visceral Leishmaniasis?1999 · 60 citations
  5. 5Miltefosine, an Oral Agent, for the Treatment of Indian Visceral Leishmaniasis1999 · 466 citations